Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001354488-16-008230
Filing Date
2016-08-29
Accepted
2016-08-29 17:54:42
Documents
1
Period of Report
2016-08-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT issuerdirect_section16.html 4  
1 PRIMARY DOCUMENT issuerdirect_section16.xml 4 6764
  Complete submission text file 0001354488-16-008230.txt   8158
Mailing Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921
Business Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921 908-517-9500
CorMedix Inc. (Issuer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Markvicka Taunia (Reporting) CIK: 0001545282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34673 | Film No.: 161858934